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Background
Some plants associated with the treatment of diabetes are
considered toxic because the hypoglycemic effect is often
result of hepatotoxicity and b-adrenergic blockade. The
Carnauba Powder produces a yellowish solid named PCO-
C, which is predominantly composed of esters of cinnamic
acid and has a chemical structure very similar to other
compounds that have been described in the literature with
a significant hypoglycemic effect, such as gamma-oryzanol
and policosanol. Therefore, it is necessary to carry out
acute toxicity tests to assess the PCO-C is safe for thera-
peutic use.
Objective
The aim of the present work it was assess the acute
toxicity of PCO-C in healthy mice.
Materials and methods
To obtain the PCO-C, the same were extracted and iso-
lated from the dust of unopened leaves of the carnaubeira,
yielding a yellowish solid. Twelve C57BL/6, male mice
between seven and eight weeks old, which they were kept
under temperature 22 °C in light-dark cycle (12 in 12 h)
and received standard chow and water ad libitum. The
Ethics Committee on Animal Research approved the
experimental protocol (no. 90/10) of this study. The mice
were divided into 2 groups (n=6), saline and PCO-C, and
was fasted for 4 h. After this period, they were adminis-
tered, by gavage, saline (1 mL/Kg) and PCO-C solution in
the dose of 2000mg/Kg. The animals had their behavior
observed in the times 30, 60,90, 120, 150, 180, 210, 240,
270 and 300 min after the end of gavage. After the beha-
vioral observation of the animals, their weight was daily
measured for 12 days. After this period, the animals were
euthanized to removal and analysis of the concerning
weight vital organs to check for acute toxicity. The analysis
of the significance differences between the data was per-
formed using nonparametric test of the Mann Whitney,
considering significant Results that had p <0.05.
Results
No death was recorded and no significant change from the
Hippocratic screening in the toxicity acute evaluation of
the PCO-C in the dose of 2000 mg/Kg. Both groups had
similar behaviors throughout the experiment. Also, there
was no statistically significant difference in weight analysis
concerning the organs (Figure 1), demonstrating the low
toxicity of the PCO-C.
Conclusion
The results indicate that the PCO-C does not have toxic
effects and is safe for therapeutic use.
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Figure 1 Result of the relative weight of organs.
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